ORPEA Announces the First Drawdown of 200 Million Euros Under the “New Money” Financing With Its Core Banking Pool
June 02 2023 - 12:34PM
Business Wire
Regulatory News:
A first drawdown of €200 million under the “new money”
financing, granted by the main banking partners of the group to
ORPEA S.A. (Paris:ORP) and its subsidiaries, Niort 94 and Niort 95,
has just been made. This amount corresponds to the totality of the
Facility D1A (the characteristics of which are described in the
press release dated May 26, 2023).
The drawn funds will be used to finance and refinance general
corporate purposes of Niort 94 including the reimbursement of the
intragroup debt due to ORPEA S.A. which will apply the proceeds to
finance in particular the general corporate purposes of the Group,
debt service and capital expenditures.
The main obligations of ORPEA S.A., Niort 94 and Niort 95, and
the securities granted to secure this “new money” financing are
described in the press release dated May 26, 2023, and the security
interests executed by ORPEA S.A. being granted within the framework
of the safeguard plan (plan de sauvegarde).
The amounts of the “new money” financing which remain undrawn to
date (and subject to certain conditions precedent) are Facilities
D1B, D2 and D3 for an aggregate amount of €400 million.
The Company is therefore continuing the execution of its
financial restructuring as per the lock-up agreement dated February
14, 2023 entered into between ORPEA S.A. and the members of the
Groupement. ORPEA S.A. will continue to inform the market of the
next steps of its implementation, in compliance with its legal and
regulatory obligations.
About ORPEA
ORPEA is a leading global player, expert in providing care for
all types of frailty. The Group operates in 21 countries and covers
three core businesses: care for the elderly (nursing homes,
assisted living facilities, homecare and services), post-acute and
rehabilitation care and mental health care (specialized clinics).
It has more than 76,000 employees and welcomes more than 267,000
patients and residents each year.
https://www.orpea-group.com/en
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a
member of the SBF 120, MSCI Small Cap Europe and CAC Mid 60
indices.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230602005276/en/
Investor Relations ORPEA Benoit Lesieur Investor
Relations Director b.lesieur@orpea.net
Toll-free number for shareholders : 0 805 480 480
Investor Relations NewCap Dusan Oresansky Tel: 01
44 71 94 94 ORPEA@newcap.eu
Press Relations ORPEA Isabelle Herrier-Naufle
Press Relations Director Tel: 07 70 29 53 74
i.herrier-naufle@orpea.net
Image7 Charlotte Le Barbier // Laurence Heilbronn 06 78
37 27 60 - 06 89 87 61 37 clebarbier@image7.fr
lheilbronn@image7.fr
Orpea (EU:ORP)
Historical Stock Chart
From Apr 2024 to May 2024
Orpea (EU:ORP)
Historical Stock Chart
From May 2023 to May 2024